Attenuation of mitochondrial oxidative stress by morin during chemical carcinogen-mediated mammary carcinogenesis

Biomedicine and Preventive Nutrition

Volumn 2, Issue 1, 2012, Pages 9-15

  Ramadass, Nandhakumar ^a   Kombiyil, Salini ^a   Kasinathan, Nirmal Kumar ^a   Sivasithamparam, Niranjali Devaraj ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Citric acid cycle enzymes; Mammary cancer; Respiratory chain enzymes

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALPHA TOCOPHEROL; CATALASE; CITRIC ACID; DIMETHYLBENZ[A]ANTHRACENE; GLUTATHIONE PEROXIDASE; MORIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CHEMOTHERAPY; CELL FUNCTION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPID PEROXIDATION; LIVER PROTECTION; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; RAT; RESPIRATORY CHAIN; SIGNAL TRANSDUCTION;

RATTUS;

EID: 84858281425     PISSN: 22105239     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bionut.2011.11.004     Document Type: Article

References (60)

1. Aggarwal B.B., Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006, 71:1397-1421.
2. Dixon R.A., Steele C.L. Flavonoids and isoflavonoids-a gold mine for metabolic engineering. Trends Plant Sci 1999, 4:394-400.
3. Middleton J.E., Kandaswami C., Theoharides T. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000, 52:673-751.
4. Wijeratne S.S., Abou-Zaid M.M., Shahidi F. Antioxidant polyphenols in almond and its coproducts. J Agric Food Chem 2006, 54:312-318.
5. Romero I., Paez A., Ferruelo A., Lujan M., Berenguer A. Polyphenols in red wine inhibit the proliferation and induce apoptosis of LNCaP cells. BJU Int. 2002, 89:950-954.
6. Xie M.X., Long M., Liu Y., Qin C., Wang Y.D. Characterization of the interaction between human serum albumin and morin. Biochim Biophys Acta 2006, 1760:1184-1191.
7. Hsiang C.Y., Wu S.L., Ho T.Y. Morin inhibits 12-O-tetradecanoylphorbol-13-acetate-induced hepatocellular transformation via activator protein 1 signaling pathway and cell cycle progression. Biochem Pharmacol 2005, 69:1603-1611.
8. Manna S.K., Aggarwal R.S., Sethi G., Aggarwal B.B., Ramesh G.T. Morin (3,5,7,2,4 -Pentahydroxyflavone) abolishes nuclear factor-kappaB activation induced by various carcinogens and inflammatory stimuli, leading to suppression of nuclear factor-kappaB-regulated gene expression and up-regulation of apoptosis. Clin Cancer Res 2007, 13:2290-2297.
9. Tanaka T., Kawabata K., Kakumoto M., Makita H., Ushida J., Honjo S., et al. Modifying effects of a flavonoid morin on azoxymethaneinduced large bowel tumorigenesis in rats. Carcinogenesis 1999, 20:1477-1484.
10. Kawabata K., Tanaka T., Honjo S., Kakumoto M., Hara A., Makita H., et al. Chemopreventive effect of dietary flavonoid morin on chemically induced rat tongue carcinogenesis. Int J Cancer 1999, 83:381-386.
11. Tanaka T., Kawabata K., Honjo S., Kohno H., Murakami M., Shimada R., et al. Inhibition of azoxymethane-induced aberrant crypt foci in rats by natural compounds, caffeine, quercetin and morin. Oncol Rep 1999, 6:1333-1340.
12. Banakar M.C., Paramasivan S.K., Chattopadhyay M.B., Datta S., Chakraborty P., Chatterjee M., et al. 1-alpha, 25-dihydroxy vitamin D3 prevents DNA damage and restores anti oxidant enzymes in rat hepatocarcinogenesis induced by diethylnitrosamine and promoted by phenobarbital. World J Gastroenterol 2004, 10:1268-1275.
13. García-Ruiz C., Colell A., Morales A., Kaplowitz N., Fernández-Checa J.C. Role of oxidative stress generated from the mitochondrial transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear kappa B: studies with isolated mitochondria and rat hepatocytes. Mol Pharmocol 1995, 48:825-834.
14. Gold P., Gold M., Freedman S.O. Cellular location of carcinoembryonic antigens of the human digestive system. Cancer Res 1968, 28:1331-1334.
15. Kim Y.S., Isaacs R., Perdomo J.M. Alterations of membrane glycopeptides in human colonic adenocarcinoma. Proc Natl Acad Sci U S A 1974, 71:4869-4873.
16. Johnson D., Lardy H. Isolation of liver and kidney mitochondria. Methods Enzymol 1967, 10:94-96.
17. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin's phenol reagent. J Biol Chem 1951, 193:265-276.
18. Ohkawa H., Ohishi N., Yagi K. Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
19. Marklund S., Marklund G. Involvement of superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974, 47:469-474.
20. Sinha A.K. Colorimetric assay of catalase. Anal Biochem 1974, 47:389-394.
21. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hajeman D.G., Hoekstra W.G. Selenium-biochemical role as a component of glutathione purification and assay. Science 1973, 179:588-590.
22. Beutler E. Active transport of glutathione disulfide from erythrocytes. Functions of glutathione: biochemical, physiological, toxicological and clinical aspects 1968, 65. Raven Press, New York. A. Larson, S. Orrenius, A. Holmgren, B. Mannerwik (Eds.).
23. Habig W.H., Pabst M.J., Jacob W.B. Glutathione-S-transferase. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974, 249:7130-7139.
24. Moron M.S., Despierre J.W., Minnervik B. Levels of glutathione, glutathione reductase and glutathione-S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979, 582:67-78.
25. Desai I.D. Vitamin E analysis methods for animal tissues. Methods Enzymol 1984, 105:138-143.
26. Omaye A.T., Turnbull J.D., Sauberdich H.E. Selected method for determination of ascorbic acid in animal cells, tissues and fluids. Methods Enzymol 1971, 62:1-11.
27. Bonting S.L. Membrane ion transport. Bio Behavioural Base of Coronary Heart Disease 1970, 1:254-363. Wiley Inter Science, London.
28. Hjerten S., Pan H. Purification and characterization of two forms of low affinity Ca2+ ATPase from erythrocyte membranes. Biochimica et Biophysica Acta 1983, 728:281-288.
29. Ohnishi T., Suzuki T., Suzuki Y., Ozawa K. A comparative study of plasma membrane Mg2+ ATPase activities in normal, regenerating and malignant cells. Biochimica et Biophysica Acta 1982, 684:67-74.
30. Williams J.N. A method for the simultaneous quantitative estimation of cytochromes a, b, c1, and c in mitochondria. Arch Biochem Biophys 1964, 107:537-543.
31. Williamson J.R., Corkey B.E. Assays of intermediates of the citric acid cycle and related compounds by fluorimetric enzymes methods. Methods in enzymology 1969, 488-491. Academic Press, New York. J.M. Lowenstein (Ed.).
32. King J. Practical clinical enzymology 1965, D. van Nostrand Company, London, p. 83-93.
33. Reed L.J., Mukherjee B.B. alpha-Ketoglutarate dehydrogenase complex from Escherichia coli. Methods Enzymol 1969, 13:55-61.
34. Slater E.C., Bonner W.D. Effect of fluoride on succinate oxidase system. Biochem J 1952, 52:185-196.
35. Mehler A.H., Kornberg A., Grisolia S., Ochoa S. The enzymatic mechanisms of oxidation reduction between malate or isocitrate and pyruvate. J Biol Chem 1948, 174:961-977.
36. Minakami S., Ringler R.L., Singer T.P. Studies on the respiratory-chain linked dihydrodiphosphopyridine nucleotide dehydrogenase. Assay of the enzyme in particulate and in soluble preparations. J Biol Chem 1962, 237:569-576.
37. Pearl N., Cancrcao J., Zweifach B.W. Micro determination of cytochrome oxidase in rat tissues by the oxidation of N-phenyl-p-phenylenediamine or ascorbic acid. J Histochem Cytochem 1963, 11:102-104.
38. Niebes P. Determination of enzymes and degradation product of glycosaminoglycan metabolism in the serum of healthy and varicose subjects. Clin Chim Acta 1972, 42:399-408.
39. Wagner W.D. More sensitive assay discriminating galactosamine and glycosamine in mixture. Anal Biochem 1979, 94:394-396.
40. Warren L. The thiobarbituric acid assay of sialic acids. J Biol Chem 1959, 234:1971-1975.
41. Dische Z., Shettles L.B. A specific colour reaction of methylpentoses and a spectrophotometric micromethod for their determination. J Biol Chem 1948, 175:595-603.
42. Maechler P., Wollheim C.B. Mitochondrial function in normal and diabetic beta-cells. Nature 2001, 414:807-812.
43. Selvendiran K., Sakthisekaran D. Chemopreventive effect of piperine on modulating lipid peroxidation and membrane bound enzymes in benzo (a)pyrene induced lung carcinogenesis. Biomed Pharmacother 2004, 58:264-267.
44. Fridovich I. Superoxide dismutases. Annu Rev Biochem 1975, 44:147-159.
45. Shimeda Y., Hirotani Y., Akimoto Y., Shindou K., Ijiri Y., Nishihori T., et al. Protective effects of capsaicin against cisplatin-induced nephrotoxicity. Biol Pharm Bull 2005, 28:1635-1638.
46. Vijayalakshmi T., Muthulakshmi V., Sachdanandam P. Salubrious effect of Semecarpus anacardium against lipid peroxidative changes in adjuvant arthritis-studied in rats. Mol Cell Biochem 1997, 175:65-69.
47. Kaplowitz N. Biochemical and cellular mechanisms of toxic liver injury. Semin Liver Dis 2002, 22:137-144.
48. Frie B., England L., Ames B.N. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A 1981, 86:6377-6381.
49. Serbecic N., Ehmann A.K., Beutelspacher S.C. Reduction of lipid peroxidation and apoptosis in corneal endothelial cells by vitamin A. Ophthalmologe 2005, 6:607-613.
50. Kako K., Kato M., Matsuoka T., Mustapha A. Depression of membrane-bound Na+-K+-ATPase activity induced by free radicals and by ischemia of kidney. Am J Physiol 1988, 254:330-337.
51. Adhirai M., Selvam R. Effect of cyclosporine A on tissue lipid peroxidation and membrane-bound phosphatases in hyperoxaluric rat and protection by vitamin E pre treatment. Jpn J Med Sci Biol 1997, 50:9-17.
52. Padma P., Setty O.H. Studies on cytochrome oxidase in carbon tetrachloride treated rats. Ind J Exp Res 1999, 37:1139-1141.
53. Aria M., Gord E.R., Leiber C.S. Increased cytochrome oxidase acidity in hepatic mitochondria after chronic ethanol consumption and possible role of decreased cytochrome aa3 content and changes in phospholipids. Biochim Biophys Acta 1984, 797:320-327.
54. Dennis J.W., Granovsky M., Warren C.E. Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta 1999, 1473:21-34.
55. Beckmann J.S., Argov Z., Mitrani R.S. The UDO-N-acetylglucosamine 2 epimerase/N acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat Genet 2001, 29:83-87.
56. Lipton A., Harvey H.A., Delong S., Allegra J., White D., Allegra M., et al. Glycoproteins and human cancer, circulating levels in cancer serum. Cancer 1979, 43:1766-1771.
57. Thompson S., Cantwell B.M.J., Cornell I., Turner G.A. Abnormally fucosylated haptoglob a cancer marker for tumour burden but not gross liver metastasis. Br J Cancer 1991, 64:386-390.
58. Dennis J.W., Kosh K., Bryce D.M., Breitman M.L. Oncogenes conferring metastatic potential induce increased branching of asn-linked oligosaccharides in rat 2 fibroblasts. Oncogene 1989, 4:853-860.
59. Aranganathan S., Senthil K., Nalini N. A case control study of glycoprotein status in ovarian carcinoma. Clin Biochem 2005, 38:535-539.
60. Freeman H.J., Kim Y., Kim Y.S. Glycoprotein metabolism in normal proximal and distal at colon and changes associated with 1,2-dimethylhydrazine-induced colonic neoplasia. Cancer Res 1978, 38:3385-3390.